Plasmodium falciparum chimeric protein 2 (PfCP-2), fused by erythrocytic stage antigens, AMA-1(III) and MSP1-19, is a potential vaccine candidate against malaria.

• 由两个疟疾疫苗候选抗原AMA 1(III)和MSP1 19融合而成的恶性疟原虫融合抗原 2 (PfCP 2 ) ,是一个很有应用前景的疟疾疫苗候选抗原。